Health Condition 1: E039- Hypothyroidism, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a. Patients of either sex with age between 18 and 60 years. b. Freshly diagnosed Patients of subclinical Hypothyroidism with elevated TSH levels between 5.5-10uIU/ml with normal T4 value. c. Patients, willing to give written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: a. TSH levels >10uIU/ml b. Patients who have undergone any type of thyroid surgery. c. Patients with uncontrolled Diabetes mellitus (HbA1C >8%). d. Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.4 mg/dl) e. Patients suffering from congenital hypothyroidism and secondary hypothyroidism. f. Patients with poorly controlled hypertension ( >= 160/100 mmHg) g. Patients who are under treatment for any thyroid disorder h. Hypertensive patients who are on β blockers. i. Symptomatic patients with clinical evidence of Heart failure. j. Alcoholics and/or drug abusers. k. H/o hypersensitivity to any of the trial drugs or their ingredients. l. Pregnant/lactating woman. m. Patients who are currently enrolled in any other clinical trial. n. Any other condition which the Investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Change in Signs and symptoms. â?¢Reduction in TSH Timepoint: 84 days | — |
Secondary
| Measure | Time frame |
|---|---|
| LFT, RFT and adverse drug reaction for safety assessmentTimepoint: 84 days | — |
Countries
India
Contacts
Central Ayurveda Research Institute